3,577
Views
8
CrossRef citations to date
0
Altmetric
Coronaviruses

SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients

SARS-CoV-2 infection impairs islet function

, , , , , , , , , , , , , , , , ORCID Icon, , & show all
Pages 1115-1125 | Received 23 Jun 2021, Accepted 24 Mar 2022, Published online: 18 Apr 2022

References

  • The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544.
  • Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415–424.
  • Puelles VG, Lutgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590–592.
  • Gupta R, Ghosh A, Singh AK, et al. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14:211–212.
  • Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36:e3319.
  • Kusmartseva I, Wu W, Syed F, et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 2020;32:1041–1051.e6.
  • Coate KC, Cha J, Shrestha S, et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 Are expressed in the microvasculature and ducts of human pancreas but Are Not enriched in β cells. Cell Metab. 2020;32:1028–1040.e4.
  • Yang L. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27:125–136.
  • Muller JA, Gross R, Conzelmann C, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3:149–165.
  • Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546–550.
  • Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Med. 2006;23:623–628.
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
  • Jin J-M, Bai P, He W, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. medRxiv. 2020. doi:10.1101/2020.02.23.20026864.
  • Michalakis K, Ilias I. COVID-19 and hyperglycemia/diabetes. World J Diabetes. 2021;12:642–650.
  • Rubino F, Amiel SA, Zimmet P, et al. New-Onset diabetes in COVID-19. N Engl J Med. 2020;383:789–790.
  • Yao XH, He ZC, Li TY, et al. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res. 2020;30:541–543.
  • World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. . 1999.
  • Toth ZE, Mezey E. Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J Histochem Cytochem. 2007;55:545–554.
  • Stack EC, Wang C, Roman KA, et al. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 2014;70:46–58.
  • Iwata M, Maeda S, Kamura Y, et al. Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals. Diabetes Care. 2012;35:1763–1770.
  • Ohkura T, Shiochi H, Fujioka Y, et al. 20/(fasting C-peptide x fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report. Cardiovasc Diabetol. 2013;12:21–28.
  • World Health Organization. Living guidance for clinical management of COVID-19. 2021.
  • Ma H, Wu X, Guo X, et al. Optimal body mass index cut-off points for prediction of incident diabetes in a Chinese population. J Diabetes. 2018;10:926–933.
  • Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–224.
  • Wang K, Chen W, Zhou Y-S, et al. Signal Transduct Target Ther. 2020;5: 283–292.
  • Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–860.
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8.
  • Aigha II, Abdelalim EM. NKX6.1 transcription factor: a crucial regulator of pancreatic β cell development, identity, and proliferation. Stem Cell Res Ther. 2020;11:459–473.
  • Moon JS, Karunakaran U, Suma E, et al. The role of CD36 in type 2 diabetes mellitus: β-cell dysfunction and beyond. Diabetes Metab J. 2020;44:222–233.
  • Berger C, Zdzieblo D. Glucose transporters in pancreatic islets. Pflügers Archiv - European Journal of Physiology. 2020;472:1249–1272.
  • White MF. Irs proteins and the common path to diabetes. American Journal of Physiology-Endocrinology and Metabolism. 2002;283:E413–E422.
  • Spaeth JM, Gupte M, Perelis M, et al. Defining a novel role for the Pdx1 transcription factor in islet β-cell maturation and proliferation during weaning. Diabetes. 2017;66:2830–2839.
  • Kim HI, Ahn YH. Role of peroxisome proliferator-activated receptor-γ in the glucose-sensing apparatus of liver and β-cells. Diabetes. 2004;53(Suppl 1):S60–S65.
  • Roper RL, Rehm KE. Sars vaccines: where are we? Expert Rev Vaccines. 2009;8:887–898.
  • Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med. 2017;376:584–594.
  • The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151.
  • Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021;12:2506–2514.
  • Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219–227.
  • Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92:699–702.
  • Xiao F, Sun J, Xu Y, et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerging Infect. Dis.. 2020;26:1920–1922.
  • Yao XH, Luo T, Shi Y, et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021;31:836–846.
  • Shojaei S, Suresh M, Klionsky DJ, et al. Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway. Virulence. 2020;11:805–810.
  • Thorens B. Glut2, glucose sensing and glucose homeostasis. Diabetologia. 2015;58:221–232.
  • Brady MJ. Irs2 takes center stage in the development of type 2 diabetes. J Clin Invest. 2004;114:886–888.
  • Spaeth JM, Walker EM, Stein R. Impact of Pdx1-associated chromatin modifiers on islet β-cells. Diabetes, Obesity and Metabolism. 2016;18(Suppl 1):123–127.
  • Marchand L, Pecquet M, Luyton C. Type 1 diabetes onset triggered by COVID-19. Acta Diabetol. 2020;57:1265–1266.
  • Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:BMI.S38440–104.
  • Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014;29:388–394.
  • Hollstein T, Schulte DM, Schulz J, et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020;2:1021–1024.
  • Wan L, Gao Q, Deng Y, et al. Gp73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia. Nat Metab. 2022;4:29–43.
  • He X, Liu C, Peng J, et al. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors. Signal Transduction and Targeted Therapy. 2022;107:e1009–e1019.
  • Laurenzi A, Caretto A, Molinari C, et al. No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2022;107:e1009–e1019.
  • Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 2021;33:479–498.